Vertaling van "new research " (Frans → Nederlands) :

TERMINOLOGIE

virus Epizootic hemorrhagic disease, New Jersey
epizootisch hemorrhagische ziekte, New Jersey-virus

virus New Minto
New Minto-virus

New York
New York

IN-CONTEXT TRANSLATIONS

FI – A new research on work stress and risk of cancer 05/03/2013
FI – A new research on work stress and risk of cancer 05-03-2013

En 2006, le gouvernement a adopté une nouvelle stratégie de R&D : Best Research for Best Health : a new national health research strategy.
In 2006 heeft de regering een nieuwe R&D-strategie opgesteld: Best Research for Best Health: a new national health research strategy.

La recherche de directives sur les “evidence based websites” classiques (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) avec les termes de recherche “ ‘pneumonia’ and ‘nursing home’ “ ne donne aucun résultat.
Zoeken op de klassieke evidence based websites voor richtlijnen (Cochrane Library, US National Clearinghouse, NICE, SIGN, New Zealand Guidelines Group, National Health and Medical Research Council, Prodigy, CMA Infobase, GAC guidelines, Primary Care Clinical Practice Guidelines, AHRQ Agency for Healthcare Research and Quality, Clinical Evidence, National Library for Health (Guideline Finder), SumSearch) met de zoekterm “ ‘pneumonia’ and ‘nursing home’ “ levert geen resultaat op.

Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.
This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.

“Pfizer’s commitments build on our ongoing efforts to fight neglected tropical diseases, which includes the work done through our support of the International Trachoma Initiative, by our colleagues who participate in our Global Health Fellows program, and through our participation in WIPO Re: Search -- a publicprivate consortium for sharing intellectual property and expertise with the global health research community to promote the development of new drugs, vaccines and diagnostics for the treatment of neglected tropical diseases, malaria and tuberculosis.
“Pfizer’s commitments build on our ongoing efforts to fight neglected tropical diseases, which includes the work done through our support of the International Trachoma Initiative, by our colleagues who participate in our Global Health Fellows program, and through our participation in WIPO Re: Search -- a publicprivate consortium for sharing intellectual property and expertise with the global health research community to promote the development of new drugs, vaccines and diagnostics for the treatment of neglected tropical diseases, malaria and tuberculosis. “We are proud to be a part of this innovative effort to support a healthier world”.

Dans le monde, Pfizer compte 3 Unités de Phase I, une à Singapour, une aux Etats-Unis à New Haven, et la troisième en Belgique à Anderlecht sur le site de l'hôpital Erasme, sur le campus universitaire du même nom. Notre Unité de Phase I de Pfizer, également appelée Pfizer Clinical Research Unit (PCRU), se trouve aux deux derniers étages de l’hôpital de jour de l’hôpital Erasme.
Onze Fase I-eenheid van Pfizer, die ook bekend staat als de Pfizer Clinical Research Unit (PCRU) bevindt zich op de twee bovenste verdiepingen van het Erasmus dagziekenhuis.

European Group on Ethics in Science and New Technologies; [http ...]
European Group on Ethics in Science and New Technologies; [http ...]

Celui-ci a été préparé par l’Institute of Environmental Science and Research Limited, ESR (New Zealand Food Safety Authority, 2010b).
Dit verslag werd voorbereid door het Institute of Environmental Science and Research Limited, ESR (New Zealand Food Safety Authority, 2010b).